Hints and tips:
Related Special Reports
...Nvidia took up all the oxygen last week, but don’t sleep on Eli Lilly. Strong earnings fuelled by weight-loss drugs have pushed the stock up 32 per cent this year....
...asset management division of BNP Paribas, the French banking group, has sent letters to 14 of the world’s largest pharmaceutical companies asking them to use a cloned substance called recombinant factor C...
...As we report today, Britain’s flagship Hinkley Point C plant is facing delays until 2029 and cost overruns rocketing to as much as £46bn....
...Tobey is adviser to many Fortune 500 companies including CVS, 3M and Eli Lilly, and regularly speaks to a range of organisations on the risks and benefits of AI....
...US regulators approved the first human pill derived from human faeces for the potentially deadly gut infection C.difficile....
...They need to be: the SkinCeuticals Vitamin C antioxidant serum is hardly a snip at £165 for 30ml....
...In response, there have been other athletes, such as the swimmer Lilly King, who’s consistently brought this up....
...John C Lechleiter Indianapolis, IN, USChairman Emeritus, Eli Lilly and Co...
...Letter in response to this article: Most Americans will hold a position in the market / From John C Lechleiter, Chairman Emeritus, Eli Lilly and Co...
...Rivals Eli Lilly and GlaxoSmithKline have also bet billions of dollars on cancer treatments over the past 18 months....
...“We don’t have drugs for viruses,” she says, adding there had only been two viruses that have been tackled successfully: Hepatitis C and HIV, which has been kept under control but not cured....
...Sanofi and Eli Lilly, which are investigating vaccines and potential treatment candidates, did not respond to requests for comment....
...It is the first new type of antidepressant since Eli Lilly launched Prozac more than 30 years ago....
...That curbs the pressure to cut prices, in contrast with pills with generic competition or, for example, a hepatitis C drug with a rival that might also be effective....
...Take Merck, which recently announced a series of rollbacks, including a 60 per cent price cut for Zepatier, a medicine for hepatitis C....
...(BBC, FT) Poop wars Faecal microbiota transplants can treat C.diff, a potentially deadly bacterial infection....
...Sporting wealth has driven African-American giving, as have the fortunes amassed in the financial sector by individuals such as Eddie C Brown, the renowned stock picker....
...(Bloomberg) News roundup Tie-up Tuesday as four US community banks consolidate (FT) UBS: wealth nuts (FT Lex) Eli Lilly plans listing of animal health unit (FT) Billionaire Alisher Usmanov explores...
...HBC's own estimates of its property value was something like C$35/share, while it trades under C$10....
...A spokesperson for Eli Lilly, the Indiana-based drugmaker, said the company was “not supportive of the sovereign immunity argument presented in the Allergan case”....
...Lilly’s Cyramza, which typically offers less than two months of survival benefit to some patients, can cost $8,000 a month....
...(Guardian, Devex) Hepatitis update The World Health Organization said 325m people were living with a chronic hepatitis B or C infection....
...Last year, Express Scripts said it would no longer cover an expensive hepatitis C medicine made by Gilead for many of its patients....
...But there is a long way to go — Lilly will not report final results from the current round of clinical trials until October next year. So much hope built into Lilly’s valuation may yet be squandered....
...In one sign of Pearson’s reputational problems in the US, the comedian Louis C. K. tweeted last year, “I trust a teacher over Pearson . . . any day of the week....
International Edition